Additional file 6 of Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)

Name: Additional file 6 of Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)
Creator: F. A. Karakostis; E. Ntoumou; M. Papasavva; E. Bothos; N. Drakoulis; P. Moulos; D. Roukas; K. Kelaidoni
Published: 2021-04-16T00:00:00+08:00

Figshare2021-04-16 更新2026-04-08 收录

药物基因组学

个性化治疗

数据链接：

https://springernature.figshare.com/articles/dataset/Additional_file_6_of_Clinical_pharmacogenomics_in_action_design_assessment_and_implementation_of_a_novel_pharmacogenetic_panel_supporting_drug_selection_for_diseases_of_the_central_nervous_system_CNS_/14429410/1 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 6: Categorization of identified PGx associations denoting altered metabolisation efficiency of CYP2C9, CYP2C19 and CYP2D6, on 501 patients, denoted as minimum (homozygotic, no polymorphism); intermediate (heterozygotic polymorphism) and enhanced (homozygotic polymorphism), including the Age and the sex factors.

提供机构：

F. A. Karakostis; E. Ntoumou; M. Papasavva; E. Bothos; N. Drakoulis; P. Moulos; D. Roukas; K. Kelaidoni

创建时间：

2021-04-16